RxSight (RXST) Other financing activities (2020 - 2026)
RxSight's (RXST) quarterly Other financing activities came in at $100000.0 in Q1 2026, down 85.71% YoY from $700000.0 in Q1 2025, and up 114.29% on a QoQ basis from -$700000.0 in Q2 2025.
RxSight (RXST) Other financing activities (2020 - 2026) Analysis & Trends
RxSight (RXST) has 7 years of Other financing activities data on file, last reported at $100000.0 in Q1 2026.
- Quarterly Other financing activities fell 85.71% year-over-year to $100000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$600000.0 (down 100.61% YoY) and the FY2024 annual result came in at $108.1 million, up 100.0% from the prior year.
- Other financing activities rose to $100000.0 in Q1 2026, from -$700000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $97.9 million in Q2 2024 to a low of -$700000.0 in Q2 2025.
- A 5-year average of $20.3 million and a median of $504000.0 in 2022 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2022 — Other financing activities sank 4300.0% — and 2023, when it surged 17448.7%.
- Tracing RXST's Other financing activities over 5 years: stood at -$308000.0 in 2022, then jumped by 17648.7% to $54.0 million in 2023, then jumped by 81.13% to $97.9 million in 2024, then sank by 100.72% to -$700000.0 in 2025, then surged by 114.29% to $100000.0 in 2026.
- The last three Other financing activities figures came in at $100000.0 (Q1 2026), -$700000.0 (Q2 2025), and $700000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | RxSight | 259.94 Mn | -144.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 100,000.00 |
| Jun 30, 2026 | 100,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Jun 30, 2025 | -700,000.00 |
| Jun 30, 2025 | -700,000.00 |
| Mar 31, 2025 | 700,000.00 |
| Mar 31, 2025 | 700,000.00 |
| Jun 30, 2024 | 97.90 Mn |
| Jun 30, 2024 | 97.90 Mn |
| Mar 31, 2024 | 10.20 Mn |
| Mar 31, 2024 | 10.20 Mn |
| Mar 31, 2023 | 54.05 Mn |
| Mar 31, 2023 | 54.05 Mn |
| Jun 30, 2022 | -308,000.00 |
| Jun 30, 2022 | -308,000.00 |
| Mar 31, 2022 | 308,000.00 |
| Mar 31, 2022 | 308,000.00 |
| Sep 30, 2021 | -410,000.00 |
| Sep 30, 2021 | -410,000.00 |